Chughtai, N. , Borger, K. , Ghafoor, A. , Nguyen, R. and Nichols, J. (2025) Beneath the Surface: The Search for Answers in a ...

Lung cancer remains the leading cause of cancer-related mortality globally. The detection rate of nodules has significantly ...

Panelists discuss how subcutaneous (SubQ) drug formulations offer practical value by significantly reducing treatment times, easing staffing pressures, and enhancing efficiency in oncology practices, ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

Multiple people were injured Sunday night in a stabbing in downtown Salem, Oregon, local police said. "The suspect is in custody," the Salem Police Department said in a short update posted to ...

Halozyme Therapeutics, Inc. (NASDAQ: HALO) (Halozyme) today announced that Bristol Myers Squibb received European Commission (EC) approval of a new Opdivo® (nivolumab) subcutaneous formulation ...

The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are enough to counter the virus, multiple scientists and federal health ...

On December 27, 2024, subcutaneous nivolumab and hyaluronidase-nvhy, marketed under the brand name Opdivo Qvantig ™, was approved by the U.S. Food and Drug Administration. About Halozyme ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...